Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: Influence of cellular composition of the graft on transplantation outcomes

Blood

Volumn 112, Issue 7, 2008, Pages 2979-2989

  Prasad, Vinod K ^a   Mendizabal, Adam ^b   Parikh, Suhag H ^a   Szabolcs, Paul ^a   Driscoll, Timothy A ^a   Page, Kristin ^a   Lakshminarayanan, Sonali ^a   Allison, June ^a   Wood, Susan ^a   Semmel, Deborah ^a   Escolar, Maria L ^c   Martin, Paul L ^a   Carter, Shelly ^b   Kurtzberg, Joanne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; CELL COMPOSITION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; DISORDERS OF PEROXISOMAL FUNCTIONS; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HLA MATCHING; HUMAN; INHERITANCE; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; ADOLESCENT; ADULT; CAUSE OF DEATH; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; DONOR; GRAFT VERSUS HOST REACTION; INBORN ERROR OF METABOLISM; INFANT; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; SURVIVAL RATE; THROMBOCYTE; UNITED STATES;

ADOLESCENT; ADULT; BLOOD PLATELETS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; METABOLISM, INBORN ERRORS; MULTIVARIATE ANALYSIS; NEUTROPHILS; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 53449089638     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-140830     Document Type: Article

References (46)

1. Vellodi A. Lysosomal storage disorders. Br J Haematol. 2005;128:413-431.
2. WhitleyCB. Belani KG, Chang PN.et al. Longterm outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genetics. 1993;46:209-218.
3. Vellodi A, Young E. New M. Pot-Mees C, Hugh-Jones K. Bone marrow transplantation for Sanfilippo disease type B. J Inherited Metabol Dis. 1992:15:911-918.
4. Shapiro E, Krivit W, Lockman L et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet. 2000:356:713-718.
5. Peters C. Balthazor M, Shapiro EG. et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood. 1996:87:4894-4902.
6. Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome. II: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood. 1998:91:2601-2608.
7. Peters C. Charnas LR, Tan Y. et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004:104:881-888.
8. Miano M, Lanino E, Gatti R, et al. Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation. Bone Marrow Transplant. 2001 27:747-751.
9. Malm G, Ringden O, Winiarski J, et al. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant. 1996;17:1003-1008.
10. Krivit W, Pierpont ME, AyazK, et al. Bonemarrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): biochemical and clinical status 24 months after transplantation. N Engl J Med. 1984;311:1606-1611.
11. Krivit W, Shapiro E, Kennedy W, et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med. 1990:322:28-32.
12. Krivit W, Shapiro EG, Peters C, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med. 1998;338:1119-1126.
13. Hobbs JR, Hugh-Jones K, Barrett AJ, et al. Reversal of clinical features of Hurlers disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet. 1981;2: 709-712.
14. Guffon N, Souillet G, Maire I, et al. Juvenile metachromatic leukodystrophy: neurological outcome two years after bone marrow transplantation. J Inherited Metabol Dis. 1995;18:159-161.
15. Aubourg P, Blanche S, Jambaque I, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990:322:1860-1866.
16. Prasad VK, Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 2008;41:99-108.
17. Cogle CR, Yachnis AT, Laywell ED, et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet. 2004; 363:1432-1437.
18. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 1988:239:290-292.
19. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A. 1997;94:4080-4085.
20. Barker JN, Davies SM, Defor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001;97:2957-2961.
21. Broxmeyer HE, Kurtzberg J, Gluckman E, et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells. 1991;17:313-329.
22. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069-2081.
23. Gluckman E, Broxmeyer HA. Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989:321:1174-1178.
24. Gluckman E. Bone marrow transplantation in children with hereditary disorders [review]. Curr Opin Pediatr. 1996;8:42-44.
25. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157-166.
26. Martin PL, Carter SL, Kernan NA, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006; 12:184-194.
27. Rocha V, Cornish J, Sievers EL. et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962-2971.
28. Rubinstein P, Carrier C, ScaradavouA, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998:339:1565-1577.
29. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996; 88:795-802.
30. Beam D, Poe MD, Provenzale JM, et al. Outcomes of unrelated umbilical cord blood transplantation for x-linked adrenoleukodystrophy. Biol Blood Marrow Transplant. 2007:13:665-674.
31. Staba SL, Escolar ML, Poe M et al. Cord-blood transplants from unrelated donors in patients with Hurlers syndrome. N Engl J Med. 2004;350: 1960-1969.
32. Wenger DA, Williams C. Screening for lysosomal disorders. In: Hommes FA, ed. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. New York: Wiley-Liss. 1991:587-617.
33. DeGasperi R, Raghavan SS, Sosa MG, et al. Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (Maroteaux-Lamy). Bone Marrow Transplant. 2000;25:541-544.
34. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92: 10119-10122.
35. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
36. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I: diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005; 11:945-956.
37. Gooley TA. Leisenring W. Crowley J. Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999:18:695-706.
38. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988:16:1141-1154.
39. Kaplan EL. Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958:53:457-481.
40. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959:22:719-748.
41. Cox DR. Regression models and life-tables. J Royal Stat Soc Series B. 1972:34:187-220.
42. Wall DA, Carter SL. Kernan NA, et al. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant. 2005; 11:637-646.
43. Page KM, Wood S, Prasad VK, Szabolcs P, Kurtzberg J. Post transplant autoimmune hemolytic anemia and other cytopenias are increased in young babies undergoing unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2007; 13:64.
44. Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism [review]. J Inherited Metabol Dis. 2006:29:413-420.
45. Boelens JJ. Wynn RF. O'Meara A. et al. Outcomes of hematopoietic stem cell transplantation for Hurlers syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant. 2007:40:225-233.
46. SouilletG, Guffon N, Maire I, et al. Outcome of 27 patients with Hurlers syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant. 2003:31:1105-1117.